SCHEMBL5370064

SCHEMBL5370064

O=C1Nc2ccc(I)cc2C1=Cc1ccc(O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.71
PSEN2 P49810 1/20 0.71
APH1B Q8WW43 1/20 0.71
NCSTN Q92542 1/20 0.71
APH1A Q96BI3 1/20 0.71
PSENEN Q9NZ42 1/20 0.71
LRRK2 Q5S007 1/20 0.71
MAPT P10636 4/20 0.70
RAF1 P04049 3/20 0.70
APP P05067 3/20 0.70
PLK4 O00444 3/20 0.70
MAP1LC3B Q9GZQ8 2/20 0.70
PLK1 P53350 2/20 0.70
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
EGFR P00533 1/20 0.70
NTRK1 P04629 1/20 0.70
ARAF P10398 1/20 0.70
PIM1 P11309 1/20 0.70
BRAF P15056 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7134225 0.89 MAPT (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5373326 0.86 MAPT (0.70) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7138082 0.86 MAPT (0.70) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7132904 0.86 MAPT (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5366800 0.86 MAPT (0.70) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5358659 0.85 LRRK2 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5366302 0.85 MEN1 (0.73) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6690796 0.84 RAF1 (0.76) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7140867 0.84 RAF1 (0.76) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6689356 0.84 PLK4 (0.78) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK PSEN1 3695/4885PSEN2 3641/4885APH1B 4435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.